Protocol - Current Contraception Use - Male
Male participants are asked about contraception use in the last 12 months.
The National Survey of Family Growth (NSFG) provides a card of response categories to the respondent. For example, in question 1 for males, an investigator would provide the respondent with a card listing the categories in question 1.
1. Including any methods you may have already told me about and methods you may have used only once, during the last 12 months, which of these methods did you and she use to prevent pregnancy or sexually transmitted diseases?
ENTER all that apply.
1[ ]Condom or rubber
2[ ]Withdrawal or pulling out
3[ ]Vasectomy or male sterilization
5[ ]Tubal ligation or female sterilization
6[ ]Injection (Depo-Provera® or Lunelle*)
7[ ]Spermicidal foam/jelly/cream/film/suppository
8[ ]Hormonal implant (Norplant®, Implanon ™, or Nexplanon ™)
9[ ]Rhythm or safe period
10[ ]Contraceptive patch (Ortho-Evra™)
11[ ]Vaginal contraceptive ring (Nuva Ring™)
12[ ]IUD, coil, loop
13[ ]Something else
*Lunelle is no longer available in the U.S.
Depo-Provera® is a registered trademark of Pfizer Inc.; Norplant® is the registered trademark of the Population Council for levonorgestrel-releasing capsule implants for protection against pregnancy; Ortho-Evra™ is the registered trademark of Johnson & Johnson, Iplanon™ is the registered trademark of the MERCK SHARP & DOHME B.V, Nexplanon™ is the registered trademark of the MERCK SHARP & DOHME B.V, NuvaRing® is a registered trademark of N.V. Organon Corporation (Netherlands).
Protocol Name from Source:
National Survey of Family Growth (NSFG)
Personnel and Training Required
If a computer-assisted instrument is used, computer software may be necessary to develop the instrument. The interviewer will require a laptop computer/handheld computer to administer a computer-assisted questionnaire.
|Specialized requirements for biospecimen collection||No|
|Average time of greater than 15 minutes in an unaffected individual||No|
Mode of Administration
Males 15-44 years of age.
This approach, which has been utilized in several national surveys, provides for minimal burden, as it does not require extensive questioning. It is adaptable to both men and women.
|Common Data Elements (CDE)||Male Current Contraception Use Assessment Description Text||5719178||CDE Browser|
Process and Review
The Expert Review Panel #5 (ERP 5) reviewed the measures in the Reproductive Health domain.
Guidance from ERP 5 includes the following:
· Updated protocol
· New Data Dictionary
Back-compatible: there are changes to the Data Dictionary, previous version of the Data Dictionary and Variable mapping in Toolkit archive (link)
National Survey of Family Growth (NSFG) 2013-2015 Male. NSFG CWPALLBC (CF-2).
Lepkowski, J. M., Mosher, W. D., Davis, K. E., Groves, R. M., van Hoewyk, J., & Willem, J. (2006). National Survey of Family Growth, Cycle 6: Sample design, weighting, imputation, and variance estimation. Vital Health Statistics, 2(142), 1-82.
Martinez, G. M., Chandra, A., Abma, J. C., Jones, J., & Mosher, W. D. (2006). Fertility, contraception, and fatherhood: Data on men and women from cycle 6 (2002) of the 2002 National Survey of Family Growth. Vital Health Statistics, 23(26), 1-142.
|Variable Name||Variable ID||Variable Description||dbGaP Mapping|
|PX100304010000||Including any methods you may have already more||N/A|
Current Contraception Use
April 11, 2017
Questions to assess participants’ use of contraception.
The purpose of these questions is to determine the type of contraceptive methods used by both female and male study participants. Certain methods, such as hormonal contraceptives, may be associated with gene/environment factors. Contraceptive methods might also be of interest as they relate to risk of sexually transmitted diseases.
Reproductive health, contraceptive methods, birth control, National Survey of Family Growth, NSFG